US Patent 12110343 Anti-plasma kallikrein antibodies
Patent 12110343 was granted and assigned to Takeda Pharmaceutical Company on October, 2024 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
March 2, 2022
0
Date of Patent
October 8, 2024
0
Patent Applicant
Patent Application Number
17684460
0
Patent Citations
•••
Patent Inventor Names
Stephen R. Comeau
0
Jon A. Kenniston
0
Andrew Nixon
0
Patent Jurisdiction
Patent Number
Patent Primary Examiner
CPC Code
Find more entities like US Patent 12110343 Anti-plasma kallikrein antibodies
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
